WO2001022956A2 - NEUE KOMBINATION VON LOTEPREDNOL UND β2-ADRENOZEPTOR-AGONISTEN - Google Patents
NEUE KOMBINATION VON LOTEPREDNOL UND β2-ADRENOZEPTOR-AGONISTEN Download PDFInfo
- Publication number
- WO2001022956A2 WO2001022956A2 PCT/EP2000/009392 EP0009392W WO0122956A2 WO 2001022956 A2 WO2001022956 A2 WO 2001022956A2 EP 0009392 W EP0009392 W EP 0009392W WO 0122956 A2 WO0122956 A2 WO 0122956A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- loteprednoi
- pharmaceutical preparation
- preparation according
- sympathomimetic
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Abstract
Description
Claims
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE50011340T DE50011340D1 (de) | 1999-09-30 | 2000-09-26 | Kombination von loteprednol und beta2-adrenozeptor-agonisten und ihre verwendung durch inhalation zur behandlung von asthma bronchiale |
AU79074/00A AU7907400A (en) | 1999-09-30 | 2000-09-26 | Novel combination of loteprednol and beta2-adrenoceptor agonists |
CA002389111A CA2389111C (en) | 1999-09-30 | 2000-09-26 | Novel combination of loteprednol and .beta.2-adrenoceptor agonists |
EP00969304A EP1216047B1 (de) | 1999-09-30 | 2000-09-26 | Kombination von loteprednol und beta2-adrenozeptor-agonisten und ihre verwendung durch inhalation zur behandlung von asthma bronchiale |
AT00969304T ATE306271T1 (de) | 1999-09-30 | 2000-09-26 | Kombination von loteprednol und beta2- adrenozeptor-agonisten und ihre verwendung durch inhalation zur behandlung von asthma bronchiale |
EEP200200163A EE05050B1 (et) | 1999-09-30 | 2000-09-26 | Loteprednooli ja β2-adrenoretseptori agonistide kombinatsioon, selle kasutamine, seda kombinatsiooni sisaldav farmatseutiline preparaat ja ravim ning meetod seda kombinatsiooni sisaldava ravimivalmistamiseks |
US10/089,449 US7521438B1 (en) | 1999-09-30 | 2000-09-26 | Combination of loteprednol and β2-adrenoceptor agonists |
BRPI0014374-0A BR0014374B1 (pt) | 1999-09-30 | 2000-09-26 | preparaÇço farmacÊutica, medicamento, processo para produÇço de dito medicamento e uso de uma combinaÇço de loteprednol e agonistas do adrenorreceptor beta dois. |
SI200030769T SI1216047T1 (sl) | 1999-09-30 | 2000-09-26 | Kombinacija loteprednola in agonistov beta2-adrenoceptorja in njena uporaba za zdravljenje bronhialne astme |
JP2001526168A JP5068912B2 (ja) | 1999-09-30 | 2000-09-26 | ロテプレドノールとβ2アドレナリン受容体アゴニストの新規組み合わせ |
HU0202753A HUP0202753A3 (en) | 1999-09-30 | 2000-09-26 | Pharmaceutical compositions containing novel combination of loteprednol and b2-adrenoceptor agonists and their use |
MXPA02003329A MXPA02003329A (es) | 1999-09-30 | 2000-09-26 | Combinacion novedosa de beta2 y agonistas del receptor adrenal. |
PL353487A PL196729B1 (pl) | 1999-09-30 | 2000-09-26 | Kompozycja farmaceutyczna zawierająca loteprednol i agonistę receptora ß2 adrenergicznego, lek do leczenia astmy oskrzelowej, sposób produkcji leku i jego zastosowanie |
CY20051101559T CY1105548T1 (el) | 1999-09-30 | 2005-12-15 | Συνδυασμος του loteprednol και αγωνιστων του β2-αδρενοϋποδοχεως και η χρηση του με εισπνοες για την αγωγη του βρογχικου ασθματος |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19947235A DE19947235A1 (de) | 1999-09-30 | 1999-09-30 | Neue Kombination von Loteprednol und beta¶2¶-Adrenorezeptor-Agonisten |
DE19947235.1 | 1999-09-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001022956A2 true WO2001022956A2 (de) | 2001-04-05 |
WO2001022956A3 WO2001022956A3 (de) | 2001-10-11 |
Family
ID=7924101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/009392 WO2001022956A2 (de) | 1999-09-30 | 2000-09-26 | NEUE KOMBINATION VON LOTEPREDNOL UND β2-ADRENOZEPTOR-AGONISTEN |
Country Status (20)
Country | Link |
---|---|
US (1) | US7521438B1 (de) |
EP (1) | EP1216047B1 (de) |
JP (1) | JP5068912B2 (de) |
AR (1) | AR025924A1 (de) |
AT (1) | ATE306271T1 (de) |
AU (1) | AU7907400A (de) |
BR (1) | BR0014374B1 (de) |
CA (1) | CA2389111C (de) |
CY (1) | CY1105548T1 (de) |
CZ (1) | CZ296396B6 (de) |
DE (2) | DE19947235A1 (de) |
DK (1) | DK1216047T3 (de) |
EE (1) | EE05050B1 (de) |
ES (1) | ES2248131T3 (de) |
HU (1) | HUP0202753A3 (de) |
MX (1) | MXPA02003329A (de) |
PL (1) | PL196729B1 (de) |
SI (1) | SI1216047T1 (de) |
TW (1) | TWI253930B (de) |
WO (1) | WO2001022956A2 (de) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003534273A (ja) * | 2000-05-19 | 2003-11-18 | アストラゼネカ・アクチエボラーグ | 新規組成物 |
US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
US9597396B2 (en) | 2001-04-17 | 2017-03-21 | Mylan Specialty Lp | Formoterol/steroid bronchodilating compositions and methods of use thereof |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2004285592B2 (en) * | 2003-11-03 | 2010-02-18 | Norton Healthcare, Ltd. | Soft steroid compositions for use in dry powder inhalers |
EP2221048A1 (de) * | 2009-02-18 | 2010-08-25 | Siegfried Generics International AG | Pharmazeutische Zusammensetzungen zur Inhalation |
US9238144B2 (en) * | 2013-03-14 | 2016-01-19 | Neuropace, Inc. | Optimizing data retrieval from an active implantable medical device |
WO2022016150A1 (en) * | 2020-07-17 | 2022-01-20 | Ross Peter M | Methods for the treatment of cytokine release syndromes |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5830490A (en) * | 1997-04-04 | 1998-11-03 | Weinstein; Robert E. | Method and device for organizing and coordinating the combined use of topical aerosols and oral medications for the treatment of disorders |
WO2000028979A1 (de) * | 1998-11-13 | 2000-05-25 | Jago Research Ag | Trockenpulver zur inhalation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB416950A (en) * | 1933-07-28 | 1934-09-25 | Ambrose Heal | An improved support member for beds, settees, wardrobes and other articles of furniture |
US4996335A (en) | 1980-07-10 | 1991-02-26 | Nicholas S. Bodor | Soft steroids having anti-inflammatory activity |
ZA814440B (en) * | 1980-07-10 | 1982-10-27 | Otsuka Pharma Co Ltd | Soft steroids having anti-inflammatory activity |
US4710495A (en) | 1980-07-10 | 1987-12-01 | Otsuka Pharmaceutical Co., Ltd. | Soft steroids having anti-inflammatory activity |
TW503113B (en) * | 1997-01-16 | 2002-09-21 | Senju Pharma Co | Aqueous suspension for nasal administration |
DK1014943T3 (da) * | 1997-02-05 | 2002-10-14 | Jago Res Ag | Medicinske aerosolformuleringer |
-
1999
- 1999-09-30 DE DE19947235A patent/DE19947235A1/de not_active Withdrawn
-
2000
- 2000-09-26 PL PL353487A patent/PL196729B1/pl not_active IP Right Cessation
- 2000-09-26 HU HU0202753A patent/HUP0202753A3/hu unknown
- 2000-09-26 AU AU79074/00A patent/AU7907400A/en not_active Abandoned
- 2000-09-26 CZ CZ20021095A patent/CZ296396B6/cs not_active IP Right Cessation
- 2000-09-26 EP EP00969304A patent/EP1216047B1/de not_active Expired - Lifetime
- 2000-09-26 CA CA002389111A patent/CA2389111C/en not_active Expired - Lifetime
- 2000-09-26 ES ES00969304T patent/ES2248131T3/es not_active Expired - Lifetime
- 2000-09-26 JP JP2001526168A patent/JP5068912B2/ja not_active Expired - Fee Related
- 2000-09-26 TW TW089119863A patent/TWI253930B/zh not_active IP Right Cessation
- 2000-09-26 SI SI200030769T patent/SI1216047T1/sl unknown
- 2000-09-26 MX MXPA02003329A patent/MXPA02003329A/es active IP Right Grant
- 2000-09-26 DE DE50011340T patent/DE50011340D1/de not_active Expired - Lifetime
- 2000-09-26 DK DK00969304T patent/DK1216047T3/da active
- 2000-09-26 AT AT00969304T patent/ATE306271T1/de active
- 2000-09-26 WO PCT/EP2000/009392 patent/WO2001022956A2/de active IP Right Grant
- 2000-09-26 BR BRPI0014374-0A patent/BR0014374B1/pt not_active IP Right Cessation
- 2000-09-26 US US10/089,449 patent/US7521438B1/en not_active Expired - Fee Related
- 2000-09-26 EE EEP200200163A patent/EE05050B1/xx not_active IP Right Cessation
- 2000-09-29 AR ARP000105167A patent/AR025924A1/es not_active Application Discontinuation
-
2005
- 2005-12-15 CY CY20051101559T patent/CY1105548T1/el unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5830490A (en) * | 1997-04-04 | 1998-11-03 | Weinstein; Robert E. | Method and device for organizing and coordinating the combined use of topical aerosols and oral medications for the treatment of disorders |
WO2000028979A1 (de) * | 1998-11-13 | 2000-05-25 | Jago Research Ag | Trockenpulver zur inhalation |
Non-Patent Citations (2)
Title |
---|
L.BJERMER, L.LARSSON: "Long-acting beta-2-agonists: how are they used in an optimal way?" RESPIRATORY MEDICINE, Bd. 91, Nr. 10, 1997, Seiten 587-591, XP000992766 * |
T. VAN DER MOLEN E.A.: "Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids" THORAX, Bd. 52, Nr. 6, 1997, Seiten 535-539, XP000992767 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003534273A (ja) * | 2000-05-19 | 2003-11-18 | アストラゼネカ・アクチエボラーグ | 新規組成物 |
JP2012184271A (ja) * | 2000-05-19 | 2012-09-27 | Astrazeneca Ab | 新規組成物 |
JP2015038118A (ja) * | 2000-05-19 | 2015-02-26 | アストラゼネカ・アクチエボラーグAstrazeneca Aktiebolag | 新規組成物 |
US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
US9597396B2 (en) | 2001-04-17 | 2017-03-21 | Mylan Specialty Lp | Formoterol/steroid bronchodilating compositions and methods of use thereof |
Also Published As
Publication number | Publication date |
---|---|
SI1216047T1 (sl) | 2006-02-28 |
ES2248131T3 (es) | 2006-03-16 |
AR025924A1 (es) | 2002-12-18 |
DK1216047T3 (da) | 2006-02-13 |
CZ296396B6 (cs) | 2006-03-15 |
EP1216047A2 (de) | 2002-06-26 |
EE05050B1 (et) | 2008-08-15 |
CZ20021095A3 (cs) | 2002-08-14 |
PL196729B1 (pl) | 2008-01-31 |
BR0014374A (pt) | 2002-06-25 |
JP5068912B2 (ja) | 2012-11-07 |
DE50011340D1 (de) | 2006-02-23 |
ATE306271T1 (de) | 2005-10-15 |
MXPA02003329A (es) | 2004-09-10 |
EP1216047B1 (de) | 2005-10-12 |
CA2389111A1 (en) | 2001-04-05 |
PL353487A1 (en) | 2003-11-17 |
EE200200163A (et) | 2003-04-15 |
CA2389111C (en) | 2009-04-14 |
HUP0202753A3 (en) | 2004-06-28 |
BR0014374B1 (pt) | 2012-12-25 |
TWI253930B (en) | 2006-05-01 |
WO2001022956A3 (de) | 2001-10-11 |
CY1105548T1 (el) | 2010-07-28 |
US7521438B1 (en) | 2009-04-21 |
JP2003510276A (ja) | 2003-03-18 |
DE19947235A1 (de) | 2001-04-05 |
AU7907400A (en) | 2001-04-30 |
HUP0202753A2 (hu) | 2002-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69834955T2 (de) | Neue Verwendung von Budesonide und Formoterol | |
DE69635023T2 (de) | Ulmwh (ultra-low-molecular weight heparin) zur behandlung von asthma | |
DE69938390T2 (de) | Verwendung einer zusammensetzung welche formoterol und budesonide enthält, zur verhinderung oder behandlung eines akuten astmazustandes | |
DE69530792T2 (de) | Pharmazeutische zusammensetzung enthaltend proliposomen pulver zur inhalation | |
EP1216046B1 (de) | Neue kombination von loteprednol und antihistaminika | |
CH680983A5 (de) | ||
DE4208258A1 (de) | Ciclosporin zur pulmonalen verabreichung | |
WO1998015280A1 (en) | New combination | |
EP2200603B1 (de) | Osmolyte zur behandlung von allergisch bedingten atemwegserkrankungen | |
EP1526870B1 (de) | Kombination von loteprednoletabonat und dfho zur behandlung von atemwegserkrankungen, allergischen erkrankungen, asthma und copd | |
DE60111025T2 (de) | Verwendung von Topiramat zur Behandlung und Diagnostizierung von Atemstörungen während des Schlafens und Mittel zur Durchführung der Behandlung und Diagnose | |
WO2001022956A2 (de) | NEUE KOMBINATION VON LOTEPREDNOL UND β2-ADRENOZEPTOR-AGONISTEN | |
DE69812028T2 (de) | Creatine Derivate für Asthma | |
DE3117327C2 (de) | ||
WO1996037198A1 (de) | Inhalative verwendung von antidepressiva zur behandlung von asthma | |
EP1009408A1 (de) | Neue kombination von antiasthmatischer arzneimittel | |
DE19810999A1 (de) | Verwendung von Sphingosin, Sphingosin-1-Phosphat, Sphingosin-1-Phosphat-Derivaten und/oder deren Gemischen zur Behandlung von entzündlichen Hautkrankheiten | |
EP0442350B1 (de) | Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung | |
DE60221640T2 (de) | Bimodale trockenpulverzusammensetzung zur inhalation | |
DE60202299T2 (de) | Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten | |
DE3827953C2 (de) | ||
EP0002803B1 (de) | Cis-(3,3,5)-Trimethylcyclohexanol zur Verwendung bei der Behandlung von Galleleiden | |
DE60036640T2 (de) | Mittel zum stimulieren von körpergewichtzunahme, verfahren und produkt | |
DE3844798C2 (en) | Medicaments contg. Urtica kiovensis extract | |
WO2022106112A1 (de) | Neues therapiekonzept für die behandlung von corona-infektionen, insbesondere covid-19-infektionen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU BG BR BY CA CN CZ DZ EE GE HR HU ID IL IN IS JP KG KR KZ LT LV MK MX NO NZ PL RO RU SG SI SK TR UA US UZ YU ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU BG BR BY CA CN CZ DZ EE GE HR HU ID IL IN IS JP KG KR KZ LT LV MK MX NO NZ PL RO RU SG SI SK TR UA US UZ YU ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000969304 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2001 526168 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2002/003329 Country of ref document: MX Ref document number: PV2002-1095 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2389111 Country of ref document: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 2000969304 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10089449 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: PV2002-1095 Country of ref document: CZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 2000969304 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: PV2002-1095 Country of ref document: CZ |